Data from: Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients
- DOI
- 10.5061/dryad.rm7dd
- Published
- 2018
- Container
- Not recorded
- Publisher
- Dryad
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/publicdomain/zero/1.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5061/dryad.rm7dd,
title = {Data from: Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients},
author = {Armas-López, Leonel and Piña-Sanchez, Patricia and Arrieta, Oscar and Guzman de Alba, Enrique and Ortiz-Quintero, Blanca and Santillán-Doherty, Patricio and Christiani, David C. and Zúñiga, Joaquín and Ávila-Moreno, Federico},
year = {2018},
doi = {10.5061/dryad.rm7dd},
url = {https://doi.org/10.5061/dryad.rm7dd}
}RIS
TY - JOUR TI - Data from: Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients AU - Armas-López, Leonel AU - Piña-Sanchez, Patricia AU - Arrieta, Oscar AU - Guzman de Alba, Enrique AU - Ortiz-Quintero, Blanca AU - Santillán-Doherty, Patricio AU - Christiani, David C. AU - Zúñiga, Joaquín AU - Ávila-Moreno, Federico PY - 2018 DO - 10.5061/dryad.rm7dd UR - https://doi.org/10.5061/dryad.rm7dd ER -
APA
Leonel, A., Patricia, P., Oscar, A., Enrique, G. D. A., Blanca, O., Patricio, S., C., C. D., Joaquín, Z., & Federico, Á. (2018). Data from: Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients. https://doi.org/10.5061/dryad.rm7dd
Source records
- datacite · retrieved 2026-09-27T18:00:05.185Z